Video is available - Log in to view. You must be registered to the event to view content
For attending this session, you can claim 1.5 EACCME credits
After this session, the attendees should be able to:
1) Learn the characteristics of HLA molecular mismatch load to identify patients at risk of dnDSA
2) Elaborate on the diagnostisis of ABMR without detectable HLA antibodies
3) Learn the significance of using artificial intelligence to leverage the diagnostic benefit of transplant liquid biopsy
4) Learn the features of CRİSPR applications in allograft rejection
Valeria R Mas, United States
Applications of CRISPR technologies in allograft rejection
Marisa G Crespo-Leiro, Spain
HLA molecular mismatch load to identify patients at risk of dnDSA production
Prof. Elaine F. Reed, United States
ABMR without detectable HLA antibodies - quo vadis?
Pinaki Sarder, United States
Application of artificial intelligence to leverage the diagnostic utility of renal transplant biopsies
